2023 Was a tough calendar year with the biopharma marketplace, with various organizations downsizing and restructuring their workforces to remain afloat. There are indications of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and daily life sciences marketplace from the latter Section of 2023 and also have ongoing https://sites.google.com/view/bio-sites/blog